content_top
43 companies, 1 interpreter! Insight, foresight
and recommendation 

AxoGen, Inc. (AXGN)

18.25
0.10
(0.55%)
Sep 11, 4:00PM EDT
content_middle

AxoGen (AXGN) is a medical technology company dedicated to peripheral nerve repair. AXGN's portfolio of regenerative medicine products is available in the United States, Canada and several other countries and includes Avance® Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site, AxoGuard® Nerve Connector, a porcine submucosa extracellular matrix ("ECM") coaptation aid for tensionless repair of severed nerves, and AxoGuard® Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments.  Avance® Nerve Graft is processed in the US by AxoGen. AxoGuard® Nerve Connector and AxoGuard® Nerve Protector are manufactured in the US by Cook Biotech Incorporated, and are distributed worldwide exclusively by AXGN. 

Previous Close: 
18.15
Open: 
18.00
Bid: 
17.60
Ask: 
21.70
1yr Target Price: 
18.67
Day's Range: 
17.90 - 18.40
52wk Range: 
7.65 - 18.50
Volume: 
208290
Average Daily Volume: 
199324
Market Capitalization: 
606.63M
Trailing Annual Dividend Yield: 
0.00
Shares Outstanding: 
33240000M
content_right

Pages